Showing results (1-10 of 324) with videos related to
Sort By:
Pageof 33
Current Opinion in Oncology|June 8, 2015
Surveillance recommendations for patients with germline TP53 mutationsMandy L Ballinger, Gillian Mitchell, David M ThomasRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 15, 2016
Diagnosis and Management of Hereditary SarcomaDavid M Thomas, Mandy L BallingerJournal of Surgical Oncology|October 23, 2014
Etiologic, environmental and inherited risk factors in sarcomasDavid M Thomas, Mandy L BallingerGenes, Chromosomes & Cancer|November 2, 2018
Translating genomic risk into an early detection strategy for sarcomaMandy L Ballinger, Mark Pinese, David M ThomasThe Lancet. Oncology|June 13, 2015
Clinical implications of genomics for cancer risk geneticsDavid M Thomas, Paul A James, Mandy L BallingerJournal of Community Genetics|May 26, 2015
Timing and context: important considerations in the return of genetic results to research participantsKate A McBride, Nina Hallowell, Martin H N Tattersall, et al.Nature Reviews. Clinical Oncology|March 20, 2014
Li-Fraumeni syndrome: cancer risk assessment and clinical managementKate A McBride, Mandy L Ballinger, Emma Killick, et al.Plos One|July 30, 2013
High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohortGillian Mitchell, Mandy L Ballinger, Stephen Wong, et al.Asia-Pacific Journal of Clinical Oncology|March 1, 2016
International survey of awareness of genetic risk in the clinical sarcoma communityKate A McBride, Timothy E Schlub, Mandy L Ballinger, et al.Familial Cancer|January 27, 2017
Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?Kate A McBride, Mandy L Ballinger, Timothy E Schlub, et al.Pageof 33